Cerebral vasospasm (CVS) is a potentially lethal complication of aneurysmal subarachnoid
hemorrhage (aSAH). Recently, the symptomatic presentation of CVS has been termed …

Background and Purpose—The goal of the Stroke Treatment Academic Industry Roundtable
(STAIR) meetings is to advance the development of acute and restorative stroke therapies …

Endovascular treatment, including intraarterial vasodilators and transluminal balloon
angioplasty, has a very important place in the management of symptomatic vasospasm …

Subarachnoid hemorrhage (SAH) is characterized by bleeding into the subarachnoid space,
often caused by ruptured aneurysm. Aneurysmal rupture occurs in 700,000 individuals per …

Cerebral vasospasm following aneurysmal subarachnoid hemorrhage (SAH) is a delayed,
reversible narrowing of the intracranial vasculature that occurs most commonly 4 to 14 days …

Structured Abstract Background The management of acute ischemic stroke (AIS) was
revolutionized within the last 15 years with the introduction of mechanical thrombectomy …

Magnesium offers theoretic vascular and neuroprotective benefits for patients with
subarachnoid hemorrhage. An electronic literature search was conducted to identify original …

BACKGROUND: Considerable controversy exists regarding the choice of balloon used for
performing angioplasty as treatment of cerebral vasospasm associated with subarachnoid …

Background Percutaneous transluminal angioplasty (PTA) has been introduced for
treatment of symptomatic cerebral vasospasm in patients with subarachnoid hemorrhage …

Background Intravenous dantrolene has been used to prevent and treat cerebral
vasospasm. We report a case of refractory cerebral vasospasm treated with intra-arterial …